9939 — Kintor Pharmaceutical Balance Sheet
0.000.00%
Last trade - 00:00
- HK$420.65m
- HK$8.47m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 138 | 196 | 1,389 | 1,055 | 875 |
Net Total Receivables | 0.031 | 0.057 | 0.555 | 0.692 | 1.93 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 218 | 221 | 1,421 | 1,526 | 1,508 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 23.2 | 113 | 187 | 267 | 285 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 424 | 553 | 1,851 | 2,068 | 2,055 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 108 | 143 | 169 | 220 | 318 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 172 | 184 | 344 | 413 | 560 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Total Equity | 252 | 370 | 1,508 | 1,655 | 1,495 |
Total Liabilities & Shareholders' Equity | 424 | 553 | 1,851 | 2,068 | 2,055 |
Total Common Shares Outstanding |